Difference between revisions of "2011 EHR Quality Measure Spec 0385"
Peterbodtke (talk | contribs) |
(Added a glossary link to Action~) |
||
| Line 50: | Line 50: | ||
'''DEVELOPMENT STATUS''' (Add details here) | '''DEVELOPMENT STATUS''' (Add details here) | ||
| − | '''ACTION ITEMS / NEXT STEPS''' (Add details here) | + | '''[[ACTION~|Action]] ITEMS / NEXT STEPS''' (Add details here) |
'''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | '''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | ||
'''OPEN ISSUES / QUESTIONS''' (Add details here) | '''OPEN ISSUES / QUESTIONS''' (Add details here) | ||
Latest revision as of 21:49, 29 July 2012
MEASURE # 0385
MEASURE TITLE Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
MEASURE DESCRIPTION Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.
Documents for 2011 EHR-Based Reporting
SPREADSHEET NQF_Retooled_Measure_0385.xlsx
SPREADSHEET GOOGLE DOC URL (editable) http://spreadsheets.google.com/a/worldvista.org/ccc?key=0ArxIkIV4NePEdHVFN3VYUEgxelpXVGlVX2V6LTJoQWc&hl=en&authkey=CJWw0OkC
PDF FILE NAME NQF_HQMF_HumanReadable_0385.pdf
PDF FILE URL https://docs.google.com/fileview?id=1Z_T_Xa8CnPgmbkHJGj9FaMoBxQpCFivb8haGi6T8kCSiX0UVtpJO9DliKro0&hl=en
REGARDING MULTIPLE NUMERATORS N/A
| TARGET DATE | SOLUTION DEVELOPERS | STATUS | SPEC DEVELOPER | NUMERATOR(s) | DENOMINATOR(s) |
|---|---|---|---|---|---|
| Phase II | TBD | N/A | AMA | 1 | 1 |
SOLUTION DESIGN / TECHNOLOGY (Add details here)
SOLUTION COMPONENTS (Add details here)
DEPENDENCIES (Add details here)
COMMENTS / NOTES (Add details here)
DEVELOPMENT STATUS (Add details here)
Action ITEMS / NEXT STEPS (Add details here)
PREPARE CERTIFICATION DOCUMENTATION (Add details here)
OPEN ISSUES / QUESTIONS (Add details here)
